Smithers Pharmaceutical Development Services staff members have over 10 years of experience in bioanalytical analysis of biosimilar development. Using multiple immunoassay platforms and bio-/cell-based assays Smithers has the scientific and regulatory expertise in bioequivalence evaluation within the most stringent timeframes. Services include PK, ADA, Nab and fit-for-purpose biomarker assays.
- Immunogenicity Assays
- Bioassays
- Biomarkers Test Development
- Generic PK/TK Assay to Support Development of Large Molecules and Biosimilars
- Immuno-Oncology Assays
- Monoclonal/Polyclonal Antibody Assays
- CAR-T and TCR Assays For Cellular Therapeutic Support
- Bi-specific antibodies
- Biobetters and Biosimilars
- Bioanalytical Testing Instrumentation
- Lab Automation Equipment